Dijklander Ziekenhuis

At Dijklander Ziekenhuis, the Internal Medicine team is involved in studies focused on major cardiovascular diseases, especially acute myocardial infarction, atherosclerotic cardiovascular disease, and inherited cholesterol disorders such as heterozygous familial hypercholesterolemia. The research is aimed at improving prevention, symptom-based treatment, and long-term outcomes for people at risk of serious heart events.

• Testing new approaches for people with suspected or recurrent acute myocardial infarction
• Evaluating treatments that lower LDL cholesterol and reduce cardiovascular risk
• Studying therapies designed to prevent major heart complications in patients with elevated lipoprotein(a)

These trials reflect a strong focus on better heart protection, earlier intervention, and more effective long-term management of high-risk cardiovascular conditions.

The site also contributes to research in neoplasms, with studies centered on blood cancers such as diffuse large B-cell lymphoma and multiple myeloma. These trials are exploring improved treatment strategies, better disease control, and more precise ways to monitor how patients respond to therapy.

• Assessing new treatment combinations for newly diagnosed diffuse large B-cell lymphoma
• Studying whether added immunotherapy can improve outcomes in aggressive lymphoma
• Comparing methods to track disease burden in multiple myeloma

Research at Dijklander Ziekenhuis in this area is focused on extending remission, improving survival, and refining disease monitoring for patients with complex hematologic malignancies.